163 related articles for article (PubMed ID: 17059425)
1. Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
Hasmim M; Bieler G; Rüegg C
J Thromb Haemost; 2007 Jan; 5(1):166-73. PubMed ID: 17059425
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt.
Bezzi M; Hasmim M; Bieler G; Dormond O; Rüegg C
J Biol Chem; 2003 Oct; 278(44):43603-14. PubMed ID: 12933798
[TBL] [Abstract][Full Text] [Related]
3. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
Cheng HL; Lin CW; Yang JS; Hsieh MJ; Yang SF; Lu KH
Oncotarget; 2016 Mar; 7(9):9742-58. PubMed ID: 26848867
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine inhibits endothelial cell migration through suppression of the Rho-mediated pathway.
Ho PY; Zhong WB; Ho YS; Lee WS
Mol Cancer Ther; 2006 Dec; 5(12):3130-8. PubMed ID: 17172416
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
6. Zoledronate inhibits alphavbeta3 and alphavbeta5 integrin cell surface expression in endothelial cells.
Bellahcène A; Chaplet M; Bonjean K; Castronovo V
Endothelium; 2007; 14(2):123-30. PubMed ID: 17497369
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
Hagelauer N; Ziebart T; Pabst AM; Walter C
Clin Oral Investig; 2015 Jun; 19(5):1079-91. PubMed ID: 25261400
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
[TBL] [Abstract][Full Text] [Related]
9. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
Yang L; Tang L; Dai F; Meng G; Yin R; Xu X; Yao W
Toxicology; 2017 Aug; 389():74-84. PubMed ID: 28743511
[TBL] [Abstract][Full Text] [Related]
10. RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes.
Torsoni AS; Marin TM; Velloso LA; Franchini KG
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1488-96. PubMed ID: 15923313
[TBL] [Abstract][Full Text] [Related]
11. Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor.
Liao WX; Feng L; Zheng J; Chen DB
Endocrinology; 2010 Jul; 151(7):3432-44. PubMed ID: 20463056
[TBL] [Abstract][Full Text] [Related]
12. Zoledronate attenuates angiogenic effects of angiotensin II-stimulated endothelial progenitor cells via RhoA and MAPK signaling.
Yang JX; Chen B; Pan YY; Han J; Chen F; Hu SJ
PLoS One; 2012; 7(10):e46511. PubMed ID: 23071580
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
Okamoto S; Jiang Y; Kawamura K; Shingyoji M; Tada Y; Sekine I; Takiguchi Y; Tatsumi K; Kobayashi H; Shimada H; Hiroshima K; Tagawa M
Cell Death Dis; 2014 Nov; 5(11):e1517. PubMed ID: 25393473
[TBL] [Abstract][Full Text] [Related]
14. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells.
Montiel M; de la Blanca EP; Jiménez E
Biochem Biophys Res Commun; 2005 Feb; 327(4):971-8. PubMed ID: 15652490
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the RhoA pathway in human endothelial cell spreading on type IV collagen: role of calcium influx.
Masiero L; Lapidos KA; Ambudkar I; Kohn EC
J Cell Sci; 1999 Oct; 112 ( Pt 19)():3205-13. PubMed ID: 10504326
[TBL] [Abstract][Full Text] [Related]
17. Palladium (II) complex and thalidomide intercept angiogenic signaling via targeting FAK/Src and Erk/Akt/PLCγ dependent autophagy pathways in human umbilical vein endothelial cells.
Aydinlik S; Uvez A; Kiyan HT; Gurel-Gurevin E; Yilmaz VT; Ulukaya E; Armutak EI
Microvasc Res; 2021 Nov; 138():104229. PubMed ID: 34339726
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells.
Meriane M; Duhamel S; Lejeune L; Galipeau J; Annabi B
Stem Cells; 2006 Nov; 24(11):2557-65. PubMed ID: 16931773
[TBL] [Abstract][Full Text] [Related]
19. Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase.
Zheng S; Huang J; Zhou K; Xiang Q; Zhang Y; Tan Z; Simoncini T; Fu X; Wang T
J Cell Mol Med; 2012 Feb; 16(2):296-305. PubMed ID: 21418517
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
